Symptom-centric view
Abdominal pain upper
Substances reporting Abdominal pain upper disproportionately — ranked by ROR.
showing 11 of 11
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tretinoin Retin-A · Atralin | 4.3 [3.9–4.8] | 351 | injectables | new |
tirzepatide Mounjaro · Zepbound | 2.3 [2.2–2.4] | 3,085 | glp-1 | new |
semaglutide Ozempic · Wegovy | 4.1 [3.9–4.2] | 3,169 | glp-1 | new |
| 2.8 [2.8–2.9] | 4,214 | algemeen | new | |
| 2.8 [2.6–3.0] | 564 | algemeen | new | |
| 3.1 [2.8–3.4] | 498 | algemeen | new | |
| 2.7 [2.6–2.7] | 6,212 | algemeen | new | |
| 2.7 [2.6–2.7] | 6,220 | algemeen | new | |
| 2.1 [2.1–2.1] | 13,092 | algemeen | new | |
| 3.4 [3.2–3.7] | 611 | algemeen | new | |
| 2.4 [2.2–2.6] | 579 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).